Skip to main content Back to Top
Advertisement

Provider Status Update

Broadcast Date: September 25, 2023

 

Subscribe on iTune PodcastsListen on Google PlaySubscribe to Stitcher Podcasts Listen on Spotify Subscribe to TuneIn PodcastsSubscribe to iHeartRadio

This podcast will update members on ASHP’s ongoing efforts to advance pharmacist provider status. We’ll cover the new bills making their way through Congress and the latest developments in the states.

SPEAKERS

Tom KrausTom Kraus, JD, (he/him) is vice president for government relations at ASHP. He is a graduate of University of Michigan (BS Biology), Georgetown University Law Center (Doctor of Law), and The Johns Hopkins University (MHS, Health Policy).

Tom previously served as the chief of staff and associate commissioner for legislation at the U.S. Food and Drug Administration. He was also a senior policy advisor to Sen. Ted Kennedy and Sen. Tom Harkin on the Senate Health, Education, Labor and Pensions Committee, where he served as deputy staff director for health.

Jillanne Schulte WallJillanne Schulte Wall, JD, (she/her) is the Senior Director of Health & Regulatory Policy for the American Society of Health-System Pharmacists (ASHP) in Bethesda, MD. She serves as ASHP’s primary liaison to federal regulatory agencies and, in conjunction with other members of the Government Relations team, develops and communicates of ASHP’s positions on federal and state laws, regulations, and guidance related to the profession of pharmacy.  Additionally, Jillanne works closely with stakeholders in pharmacy, medicine, manufacturing, and patient advocacy on legislative and regulatory issues of importance to ASHP members.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.